Of the 88,902 patients studied for 22 years, 1,815 developed colorectal cancer. Researchers believe 40 percent of cases could’ve been prevented with a colonoscopy.
A colonoscopy reaches the entire colon, whereas a signoidoscopy only reaches the lower third of the colon.
More Articles on Gastroenterology:
Dr. Gabriel Lee Joins Area Gastroenterology in Houston
Stem Cell Infusion May Be Viable Crohn’s Disease Treatment, Study Says
FDA Approves Celgene’s Supplemental New Drug Application for Pancreatic Cancer Treatment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.